StudyPeer-reviewed research publisher
- Source type
- Study
- Access type
- Publisher
- Publisher
- BMJ
- Date
- 2026
- Added
- 2026-06-19
Trust profile
88
Peer-reviewed research publisher
- Publisher type
- Peer-reviewed journal
- Bias profile
- Moderate
Best used for
- Primary studies
- Systematic reviews
- Mechanistic research
Weak for
- Regulatory status
- Universal consumer recommendations
Used in Viral Vitalism
Primary sourcesignal6 references
GLP-1s, Dopamine, and Addiction: The Substance Use Signal
Roles: Primary source
Primary sourcestudy1 reference
Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes
Roles: Primary source
Show section-level references
Claims supported
- Observational studies report associations between GLP-1 use and several substance-use outcomes, but they cannot establish causality or treatment effectiveness.
Related studies
Related sources
Trial registryClinical trial registry
Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder
Trial registry for oral semaglutide among adults with AUD.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Does Semaglutide Reduce Alcohol Intake
Trial registry for semaglutide and alcohol intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Trial registryClinical trial registry
Effects of Semaglutide on Nicotine Intake
Trial registry for semaglutide and nicotine intake.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 2 connections
Trial registryClinical trial registry
ESSENCE clinical trial registry
ClinicalTrials.gov used across the Viral Vitalism evidence library.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 3 connections
Trial registryGovernment health research
ESSENCE phase 3 trial design for semaglutide in MASH
PubMed used across the Viral Vitalism evidence library.
- Trust score
- 91
- Publisher
- PubMed
- Indexed by
- PubMed
- Access
- Abstract/index
- Usage
- 2 connections
Trial registryClinical trial registry
GLP-1R Agonist Treatment for Opioid Use Disorder
Trial registry testing whether semaglutide can reduce illicit opioid use in adults in outpatient OUD treatment.
- Trust score
- 84
- Publisher
- ClinicalTrials.gov
- Access
- Official
- Usage
- 1 connection
Topic tags
glp-1substance-use-disorderveteranstype-2-diabetesobservational